title: Do pentoxifylline and ascorbic acid improve erythropoiesis stimulating agent resistance?
authors.affiliation: Section of Nephrology, Department of Medicine, Saint Mary's Hospital, Waterbury Yale University School of Medicine, New Haven, Connecticut 06706, USA. mirarho@optonline.net
authors.forename: Mira
authors.initials: M
authors.lastname: Rho
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D001205:Ascorbic Acid / Q000627:therapeutic use*; D004351:Drug Resistance; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D010431:Pentoxifylline / Q000627:therapeutic use*
chemical_list: D006397:Hematinics; D001205:Ascorbic Acid; D010431:Pentoxifylline